期刊文献+

MDR1基因多态性对相关药物药动学影响研究进展 被引量:5

Advances in the influence of MDR1 gene polymorphisms on pharmacokinetics of related drugs
下载PDF
导出
摘要 药物在体内的处置通常是由转运蛋白参与完成的。其中的P-糖蛋白(P-gp),由多药耐药基因MDR1编码,其作用是加速药物从这些组织的外排。MDR1基因多态性直接影响P-gp的分布和功能,并影响着P-gp底物药物的体内处置。因此对于不同基因型编码的P-gp的生理和生化功能的进一步研究对个体化药物治疗非常重要。本文就目前研究较多的MDR1基因单核苷酸多态性对不同底物的药动学影响进行了综述,为临床个体用药提供一定的参考。 Transport proteins involve in drug disposition in vivo.P-glycoprotein,encoded by multidrug resistance1,accelerates the drug efflux from those tissues.MDR1 gene polymorphisms not only has an direct influence on the distribution and function of P-gp,but also has an impact on the disposition of its substrates.Further study of physiological and biochemical function on different genetype encoding P-gp could be very important in individual treatment.This article reviews recent studies of influence of single nucleotide polymorphisms of MDR1 gene on the pharmacokinetics of substrates and this can provide references for clinical individualized therapy.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第10期1191-1196,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 MDR1 基因多态性 P-糖蛋白 药动学 MDR1 Gene polymorphisms P-glycoprotein Pharmacokinetics
  • 相关文献

参考文献35

  • 1Li YH,Wang YH,Li Y, et al. MDR1 gene poly morphisms and clinical relevance[J]. Acta Genet Sinica,2006,33(2) :93-104. 被引量:1
  • 2Hoffmann U,Kroemer HK. The ABC transporters MDR1 and MRP2.. multiple functions in disposition of xenobiotics and drug resistance[J]. Drug Metab Rev, 2004,36 (3/4):669-701. 被引量:1
  • 3许景峰.药物基因组学应用于临床药学是个体化用药的必然趋势[J].药学服务与研究,2009,9(3):161-165. 被引量:14
  • 4徐萍,李焕德.多药耐药基因MDR1多态性的研究进展[J].中国临床药理学杂志,2006,22(6):464-467. 被引量:7
  • 5Kung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function[J]. Biochimt Biophys Acta,2009,1794(5) :860-871. 被引量:1
  • 6Jeannesson E, Siest G, Bastien B, et al. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort[J]. Clin Chim Acta,2009,403(1/2) : 198-202. 被引量:1
  • 7Mahadevan D,List AF. Targeting the multidrug re sistance-1 transporter in AML.. molecular regulation and therapeutic strategies[J]. Blood,2004,104(7): 1940-1951. 被引量:1
  • 8Chen S,Huo X,Lin Y,et al. Association of MDR1 and ERCC1 polymorphisms with response and tox icity to cisplatin-based chemotherapy in non-smallcell lung cancer patients [J]. Int J Hyg Environ Health,2010,213(2) :140-145. 被引量:1
  • 9Pal D, Mitra AK. MDR- and CYP3A4 mediated drug-herbal interations[J]. Life Sei, 2006,78 (18) : 2131-2145. 被引量:1
  • 10Hoffmeyer S, Burk O, Von R tional polymorphisms of the ichter C, et al. Func human gene: multiple sequence variations and cor relation of one allele with P-glycoprotein expression and activity in vivo[J]. Proc Natl Acad Sci U S A, 2000,97(7) :3473-3478. 被引量:1

二级参考文献119

共引文献31

同被引文献66

  • 1胡永芳,周宏灏.CYP3A4,CYP3A5和MDR1基因多态性对环孢素处置的影响[J].中国药理学通报,2005,21(3):257-261. 被引量:34
  • 2邵丽佳,徐瑞龙,朱以军.肾移植患者口服环孢素A的血药浓度监测分析[J].中国现代应用药学,2007,24(3):247-248. 被引量:12
  • 3吴逢波,陈泽莲,徐珽,唐尧.CYP2C9基因多态性与合理用药研究[J].中国药房,2007,18(29):2308-2309. 被引量:11
  • 4Henmi K, Yoshida M, Yoshikawa N, et al. P - glyco- protein functions inperipherat - blood CD4 + cells of patients with systemic lupus erythematosus[J]. Bi- ol Pharm Bu11,2008,31(5) :873 - 878. 被引量:1
  • 5Tsujimura S, Saito K, Nawata M, et al. Overcoming drug resistance inducedby P- glycoprotein on lym- phocytes in patients with refractoryrheumatoid ar- thritis[J]. Ann Rheum Dis,2008,67(3) .. 380 - 388. 被引量:1
  • 6Cortada CM, Gil A, Goncalves S, et al. P - glycopro- tein functional activityin peripheral blood lympho- cytes in ulcerative colitis [J]. Medicina ( BAires), 2009,69(4) :437 - 441. 被引量:1
  • 7Zrlek[ A, Farlnotti R, Buyse M. Cyclooxygenase - 2 inhibitors prevent trinitrobenzene suIfonic acid- in- duced P- glyeoprotein up--regulation invitro and in vivo[J]; Eur J Pharmacol,2010,636(1-3):189'- 197. 被引量:1
  • 8Juliano RL, Ling V. A surface glycoprotein modula- ting drug permeability in Chinese hamster ovary cell mutants[J]. Biochim Biophys Acta, 1976, 455 (1) : 152- 162. 被引量:1
  • 9Padowski JM, Pollack GM. Pharmacokinetic and phar- rnacodynamic implications of P- glycoprotein modulation [J]. Methods Mol Bio1,2010,596 ..359 - 384. 被引量:1
  • 10Hoffmeyer S, Burk O,von Richter O, et al. Func- tional polymorphisms of the human multidrug - re- sistance gene_ Multiple sequence variations and cor- relation of one allele with P- glycoprotein expression and activity in vivo[J]. Proc Natl Acad SciUSA, 2000,97(7) :3473 - 3478. 被引量:1

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部